Effect of perioperative complications after endovascular therapy in patients with peripheral artery disease due to femoropopliteal lesions  Kei Sato,

Slides:



Advertisements
Similar presentations
Worse Limb Prognosis for Indirect versus Direct Endovascular Revascularization only in Patients with Critical Limb Ischemia Complicated with Wound Infection.
Advertisements

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.
Outcomes of cold-stored venous allograft for below-knee bypasses in patients with critical limb ischemia  Vincent Ziza, MD, Ludovic Canaud, MD, PhD, Thomas.
Multidisciplinary care improves amputation-free survival in patients with chronic critical limb ischemia  Jayer Chung, MD, J. Gregory Modrall, MD, Chul.
Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease  Mahmoud B. Malas, MD, MHS, Ngozi Enwerem, MBBS, Umair.
Randomized controlled trial of remote endarterectomy versus endovascular intervention for TransAtlantic Inter-Society Consensus II D femoropopliteal lesions 
Prediction rule for cardiovascular events and mortality in peripheral arterial disease patients: Data from the prospective Second Manifestations of ARTerial.
Favorable outcomes of very elderly patients with critical limb ischemia who undergo distal bypass surgery  Takuro Shirasu, MD, Katsuyuki Hoshina, PhD,
Monica S. O'Brien-Irr, MS, RN, Hasan H. Dosluoglu, MD, Linda M
The impact of body mass index on perioperative outcomes of open and endovascular abdominal aortic aneurysm repair from the National Surgical Quality Improvement.
Incidence, predictors, and prognosis of in-stent occlusion after endovascular treatment with nitinol stents for femoropopliteal lesions  Tomoharu Dohi,
Contemporary outcomes after superficial femoral artery angioplasty and stenting: The influence of TASC classification and runoff score  Daniel M. Ihnat,
A percutaneous arterial closure protocol can decrease complications after endovascular interventions in vascular surgery patients  Philip P. Goodney,
Smoking cessation is associated with decreased mortality and improved amputation- free survival among patients with symptomatic peripheral artery disease 
Endovascular treatment of long lesions of the superficial femoral artery: Results from a multicenter registry of a spiral, covered polytetrafluoroethylene.
Jayer Chung, MD, David A. Timaran, MD, J
Elevated serum cystatin C level is an independent predictor of contrast-induced nephropathy and adverse outcomes in patients with peripheral artery disease.
Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects)  William R. Hiatt,
Finnvasc score and modified Prevent III score predict long-term outcome after infrainguinal surgical and endovascular revascularization for critical limb.
PC152. Risk Associated With Female Gender for More Advanced Peripheral Arterial Disease at Time of Femoropopliteal Bypass Remains Constant from 2003 to.
Outcomes of polytetrafluoroethylene-covered stent versus bare-metal stent in the primary treatment of severe iliac artery obstructive lesions  Michele.
Favorable outcomes of very elderly patients with critical limb ischemia who undergo distal bypass surgery  Takuro Shirasu, MD, Katsuyuki Hoshina, PhD,
Collateral artery from arteriovenous malformation of the rectum in a patient with peripheral artery disease  Hirotomo Uchiyama, MD, Reiji Hattori, MD,
Michael S. Conte, MD  Journal of Vascular Surgery 
Insulin use is associated with poor limb salvage and survival in diabetic patients with chronic limb ischemia  Hasan H. Dosluoglu, MD, Purandath Lall,
Changing pattern of surgical revascularization for critical limb ischemia over 12 years: Endovascular vs open bypass surgery  Toshifumi Kudo, MD, PhD,
Pulse palpation is an effective method for population-based screening to exclude peripheral arterial disease  Louise S. Londero, MD, Jes S. Lindholt,
Long-term results of direct and indirect endovascular revascularization based on the angiosome concept in patients with critical limb ischemia presenting.
Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent  Bao-Ngoc Nguyen,
Impact of cilostazol after endovascular treatment for infrainguinal disease in patients with critical limb ischemia  Yoshimitsu Soga, MD, Osamu Iida,
Clinical efficacy of endovascular therapy for patients with critical limb ischemia attributable to pure isolated infrapopliteal lesions  Osamu Iida, MD,
Katelynn M. Ferranti, MD, Turner M. Osler, MD, Reshma P
Attainment of low-density lipoprotein cholesterol goal after endovascular treatment is associated with reduced cardiovascular events in patients with.
Derek de Grijs, MD, Pedro Teixeira, MD, Steven Katz, MD 
Validation of the PIII CLI risk score for the prediction of amputation-free survival in patients undergoing infrainguinal autogenous vein bypass for critical.
Outcomes of infrainguinal bypass determined by age in the Vascular Study Group of New England  Meghan Dermody, MD, MS, Christopher Homsy, MD, Yuanyuan.
The number of patent tibial vessels does not influence primary patency after nitinol stenting of the femoral and popliteal arteries  Jenny J. Lee, MD,
Jayer Chung, MD, J. Gregory Modrall, MD, R. James Valentine, MD 
Clinical effects of single or double tibial artery revascularization in critical limb ischemia patients with tissue loss  Norihiro Kobayashi, MD, Keisuke.
Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions  Osamu Iida, MD, Shinsuke Nanto, MD, Masaaki Uematsu,
Utility of direct angiosome revascularization and runoff scores in predicting outcomes in patients undergoing revascularization for critical limb ischemia 
Syed N. Haider, Eamon G. Kavanagh, MD, Martin Forlee, FCS (SA), Mary P
Trends in the incidence, treatment, and outcomes of acute lower extremity ischemia in the United States Medicare population  Donald T. Baril, MD, Kaushik.
Infrainguinal cutting balloon angioplasty in de novo arterial lesions
Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery  Yoshimitsu.
The Use of Micro-Oxygen Sensors (MOXYs) to Determine Dynamic Relative Oxygen Indices in the Foot of Patients with Critical Limb Ischemia (CLI) During.
Initial and 3-year results after subintimal versus intraluminal approach for long femoropopliteal occlusion treated with a self-expandable nitinol stent 
Current efficacy of open and endovascular interventions for advanced superficial femoral artery occlusive disease  Christopher J. Smolock, MD, Javier.
Comparison of open and endovascular treatment of patients with critical limb ischemia in the Vascular Quality Initiative  Jeffrey J. Siracuse, MD, Matthew.
Karthikeshwar Kasirajan, MD, Mark D. Morasch, MD, Michel S
Toshifumi Kudo, MD, PhD, Fiona A. Chandra, Samuel S. Ahn, MD 
Todd R. Vogel, MD, MPH, Robin L. Kruse, PhD 
Lower extremity bypass vs endovascular therapy for young patients with symptomatic peripheral arterial disease  Mauri J.A. Lepäntalo, MD, Rabih Houbballah,
Sequential compression biomechanical device in patients with critical limb ischemia and nonreconstructible peripheral vascular disease  Sherif Sultan,
Plaque excision with the Silverhawk catheter: Early results in patients with claudication or critical limb ischemia  W. Brent Keeling, MD, Murray L. Shames,
Predicting loss of patency after forearm loop arteriovenous graft
Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease  Hasan H.
Peripheral atherectomy in TransAtlantic InterSociety Consensus type C femoropopliteal lesions for limb salvage  Andrea E. Yancey, MD, David J. Minion,
Endovascular treatment for carotid artery stenosis after neck irradiation  Jean-Pierre Favre, MD, Alice Nourissat, MD, Ambroise Duprey, MD, Ghislain Nourissat,
SS3. Validation of the PIII CLI Risk Score for the Prediction of Amputation-Free Survival (AFS) in Patients with Critical Limb Ischemia  Andres Schanzer,
Charles S. Joels, MD, John W. York, MD, Corey A. Kalbaugh, MS, David L
Donald T. Baril, MD, Luke K. Marone, MD, Justine Kim, Michael R
Long-term prognostic factors after thrombolysis for lower limb ischemia  Monica Kuoppala, MD, Sofia Franzén, MD, Bengt Lindblad, MD, PhD, Stefan Acosta,
Quality of life in patients with no-option critical limb ischemia underlines the need for new effective treatment  Ralf W. Sprengers, MD, Martin Teraa,
The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: A 10-year experience  Toshifumi Kudo, MD, PhD,
Prognosis of critical limb ischemia patients with tissue loss after achievement of complete wound healing by endovascular therapy  Norihiro Kobayashi,
Ten-year technical and clinical outcomes in TransAtlantic Inter-Society Consensus II infrainguinal C/D lesions using duplex ultrasound arterial mapping.
Outcomes of cold-stored venous allograft for below-knee bypasses in patients with critical limb ischemia  Vincent Ziza, MD, Ludovic Canaud, MD, PhD, Thomas.
Endovascular interventions for TASC II D femoropopliteal lesions
Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.
Presentation transcript:

Effect of perioperative complications after endovascular therapy in patients with peripheral artery disease due to femoropopliteal lesions  Kei Sato, MD, Osamu Iida, MD, Mitsuyoshi Takahara, MD, PhD, Yoshimitsu Soga, MD, Kenji Suzuki, MD, Takashi Tanigawa, MD, PhD, Masaaki Ito, MD, PhD, Masaaki Uematsu, MD, PhD  Journal of Vascular Surgery  Volume 61, Issue 5, Pages 1272-1277 (May 2015) DOI: 10.1016/j.jvs.2014.12.051 Copyright © 2015 Society for Vascular Surgery Terms and Conditions

Fig 1 Occurrence of perioperative complications (POCs) according to the number of risk factors. POCs occurred in 209 patients (9.7%). Risk factors for POCs were body mass index (BMI) <18.5 kg/m2, critical limb ischemia (CLI), and TransAtlantic Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) class D lesions (Table I). According to the number of risk factors for POCs, incidence of POCs was higher in the groups with higher scores (0: 5.0% [50 of 995], 1: 11.6% [97 of 835], 2: 18.4% [50 of 272], and 3: 27.9% [12 of 43]). Journal of Vascular Surgery 2015 61, 1272-1277DOI: (10.1016/j.jvs.2014.12.051) Copyright © 2015 Society for Vascular Surgery Terms and Conditions

Fig 2 Effect of perioperative complications (POCs) on survival free of major adverse limb events (MALE). The MALE-free survival rate was higher in the group without POCs (POC−) than in the group with POCs (POC+) up to 5 years (45% ± 2% vs 28% ± 5%; P < .001). SE, Standard error. Journal of Vascular Surgery 2015 61, 1272-1277DOI: (10.1016/j.jvs.2014.12.051) Copyright © 2015 Society for Vascular Surgery Terms and Conditions